NASDAQ : ANNX
Annexon, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.05 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 767.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 35.82M | 31.71M | 34.62M | 29.97M | 33.10M | 30.65M |
| Research & Development | 174.74M | 184.70M | 119.45M | 113.76M | 112.50M | 100.07M |
| Operating Expenses | 210.56M | 216.41M | 154.07M | 143.72M | 145.60M | 130.71M |
| Operating Income | -210.56M | -216.41M | -154.07M | -143.72M | -145.60M | -130.71M |
| Interest & Investment Income | 7.89M | 9.72M | 15.87M | 9.49M | 3.65M | 290.00K |
| EBT Excluding Unusual Items | -202.67M | -206.69M | -138.20M | -134.24M | -141.95M | -130.42M |
| Other Unusual Items | 100.00K | |||||
| Pretax Income | -202.67M | -206.69M | -138.20M | -134.24M | -141.95M | -130.32M |
| Net Income | -202.67M | -206.69M | -138.20M | -134.24M | -141.95M | -130.32M |
| Preferred Dividends & Other Adjustments | 1.86M | |||||
| Net Income to Common | -202.67M | -208.55M | -138.20M | -134.24M | -141.95M | -130.32M |
| Shares Outstanding (Basic) | 179.81M | 155.11M | 137.40M | 75.67M | 54.67M | 38.32M |
| Shares Outstanding (Diluted) | 179.81M | 155.11M | 137.40M | 75.67M | 54.67M | 38.32M |
| EPS (Basic) | -1.13 | -1.34 | -1.01 | -1.77 | -2.60 | -3.40 |
| EPS (Diluted) | -1.13 | -1.34 | -1.01 | -1.77 | -2.60 | -3.40 |
| Free Cash Flow | -193.22M | -186.49M | -118.02M | -121.33M | -122.83M | -107.76M |
| Free Cash Flow Per Share | -1.07 | -1.20 | -0.86 | -1.60 | -2.25 | -2.81 |
| EBITDA | -208.39M | -214.24M | -151.92M | -141.57M | -143.49M | -128.57M |
| D&A For EBITDA | 2.17M | 2.17M | 2.15M | 2.15M | 2.11M | 2.14M |
| EBIT | -210.56M | -216.41M | -154.07M | -143.72M | -145.60M | -130.71M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 199.27M | 162.05M | 49.50M | 225.11M | 140.02M | 74.84M |
| Short-Term Investments | 9.97M | 76.29M | 262.52M | 34.61M | 102.64M | 167.87M |
| Cash & Short-Term Investments | 209.24M | 238.34M | 312.02M | 259.72M | 242.66M | 242.72M |
| Prepaid Expenses | 3.51M | 3.85M | 4.44M | 4.14M | 5.24M | 4.51M |
| Other Current Assets | 203.00K | 463.00K | ||||
| Total Current Assets | 212.76M | 242.19M | 316.46M | 263.86M | 248.10M | 247.69M |
| Property, Plant & Equipment | 24.01M | 25.80M | 29.34M | 32.78M | 35.97M | 38.18M |
| Other Long-Term Assets | 9.30M | 9.58M | 4.27M | 1.03M | 1.03M | 1.17M |
| Total Assets | 246.07M | 277.57M | 350.07M | 297.67M | 285.10M | 287.04M |
| Accounts Payable | 15.73M | 14.93M | 10.43M | 5.49M | 7.42M | 11.15M |
| Accrued Expenses | 19.62M | 24.79M | 17.57M | 10.28M | 13.45M | 7.33M |
| Current Portion of Leases | 3.13M | 2.91M | 2.52M | 2.17M | 1.32M | 1.20M |
| Other Current Liabilities | 180.00K | 2.06M | ||||
| Total Current Liabilities | 38.48M | 42.63M | 30.51M | 17.93M | 22.36M | 21.74M |
| Long-Term Leases | 21.52M | 23.29M | 26.45M | 29.19M | 31.54M | 33.39M |
| Total Liabilities | 60.01M | 65.92M | 56.97M | 47.12M | 53.90M | 55.13M |
| Common Stock | 175.00K | 149.00K | 109.00K | 78.00K | 48.00K | 39.00K |
| Additional Paid-In Capital | 1.20B | 1.13B | 1.00B | 823.03M | 669.78M | 528.37M |
| Retained Earnings | -1.02B | -917.39M | -710.70M | -572.50M | -438.26M | -296.31M |
| Comprehensive Income & Other | -82.00K | -29.00K | 10.00K | -52.00K | -372.00K | -180.00K |
| Total Common Equity | 186.06M | 211.65M | 293.11M | 250.56M | 231.19M | 231.91M |
| Shareholders' Equity | 186.06M | 211.65M | 293.11M | 250.56M | 231.19M | 231.91M |
| Total Liabilities & Equity | 246.07M | 277.57M | 350.07M | 297.67M | 285.10M | 287.04M |
| Total Debt | 24.65M | 26.20M | 28.97M | 31.36M | 32.86M | 34.59M |
| Net Cash (Debt) | 184.59M | 212.14M | 283.05M | 228.36M | 209.80M | 208.13M |
| Net Cash Per Share | 1.03 | 1.37 | 2.06 | 3.02 | 3.84 | 5.43 |
| Filing Date Shares Outstanding | 189.58M | 160.47M | 109.71M | 90.03M | 50.49M | 38.56M |
| Total Common Shares Outstanding | 174.60M | 149.36M | 109.38M | 78.37M | 47.72M | 38.56M |
| Working Capital | 174.28M | 199.56M | 285.95M | 245.93M | 225.74M | 225.95M |
| Book Value Per Share | 1.07 | 1.42 | 2.68 | 3.20 | 4.84 | 6.01 |
| Tangible Book Value | 186.06M | 211.65M | 293.11M | 250.56M | 231.19M | 231.91M |
| Tangible Book Value Per Share | 1.07 | 1.42 | 2.68 | 3.20 | 4.84 | 6.01 |
| Machinery | 2.84M | 2.70M | 2.56M | 2.56M | 2.49M | 2.04M |
| Leasehold Improvements | 17.25M | 17.26M | 17.25M | 17.25M | 17.23M | 16.59M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -202.67M | -206.69M | -138.20M | -134.24M | -141.95M | -130.32M |
| Depreciation & Amortization | 2.17M | 2.17M | 2.15M | 2.15M | 2.11M | 2.14M |
| Loss (Gain) From Sale of Investments | -1.79M | -4.00M | -9.05M | -2.55M | 73.00K | 1.25M |
| Stock-Based Compensation | 16.11M | 16.42M | 19.43M | 18.18M | 18.52M | 16.26M |
| Other Operating Activities | 1.64M | 1.52M | 1.30M | 1.12M | 1.21M | 1.27M |
| Change in Accounts Payable | 4.19M | 4.49M | 4.94M | -2.08M | -287.00K | 3.86M |
| Change in Other Net Operating Assets | -12.68M | -261.00K | 1.43M | -3.73M | 4.03M | -575.00K |
| Operating Cash Flow | -193.03M | -186.36M | -118.01M | -121.14M | -116.31M | -106.11M |
| Capital Expenditures | -185.00K | -137.00K | -15.00K | -193.00K | -6.53M | -1.65M |
| Investment in Securities | 86.56M | 190.19M | -218.78M | 70.90M | 64.97M | -86.58M |
| Investing Cash Flow | 86.37M | 190.05M | -218.80M | 70.70M | 58.44M | -88.24M |
| Issuance of Common Stock | 177.28M | 110.47M | 163.47M | 136.08M | 130.90M | 1.79M |
| Other Financing Activities | -3.63M | -1.62M | -2.26M | -555.00K | -7.99M | |
| Financing Cash Flow | 173.64M | 108.86M | 161.21M | 135.52M | 122.91M | 1.79M |
| Foreign Exchange Rate Adjustments | 1.00K | 2.00K | -15.00K | 5.00K | 1.00K | -5.00K |
| Net Cash Flow | 66.98M | 112.55M | -175.61M | 85.09M | 65.04M | -192.56M |
| Free Cash Flow | -193.22M | -186.49M | -118.02M | -121.33M | -122.83M | -107.76M |
| Free Cash Flow Per Share | -1.07 | -1.20 | -0.86 | -1.60 | -2.25 | -2.81 |
| Levered Free Cash Flow | -115.99M | -104.48M | -62.80M | -73.67M | -76.86M | -57.20M |
| Unlevered Free Cash Flow | -115.99M | -104.48M | -62.80M | -73.67M | -76.86M | -57.20M |
| Change in Working Capital | -8.49M | 4.23M | 6.36M | -5.80M | 3.74M | 3.28M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 767.80M | 748.26M | 546.82M | 355.65M | 246.25M | 440.93M |
| Enterprise Value | 583.20M | 586.48M | 236.32M | 221.89M | 10.44M | 203.38M |
| Last Close Price | 4.05 | 5.02 | 5.13 | 4.54 | 5.17 | 11.49 |
| PB Ratio | 3.80 | 3.54 | 1.87 | 1.42 | 1.06 | 1.90 |
| P/TBV Ratio | 4.13 | 3.54 | 1.87 | 1.42 | 1.06 | 1.90 |
| Debt / Equity Ratio | 0.13 | 0.12 | 0.10 | 0.12 | 0.14 | 0.15 |
| Net Debt / Equity Ratio | -0.99 | -1.00 | -0.97 | -0.91 | -0.91 | -0.90 |
| Net Debt / EBITDA Ratio | 0.89 | 0.99 | 1.86 | 1.61 | 1.46 | 1.62 |
| Net Debt / FCF Ratio | 0.95 | 1.14 | 2.40 | 1.88 | 1.71 | 1.93 |
| Quick Ratio | 5.44 | 5.59 | 10.23 | 14.49 | 10.85 | 11.16 |
| Current Ratio | 5.53 | 5.68 | 10.37 | 14.72 | 11.10 | 11.39 |
| Return on Equity (ROE) | -105.26% | -81.90% | -50.84% | -55.73% | -61.30% | -45.24% |
| Return on Assets (ROA) | -51.54% | -43.10% | -29.73% | -30.83% | -31.81% | -25.41% |
| Return on Capital Employed (ROCE) | -101.40% | -92.10% | -48.20% | -51.40% | -55.40% | -49.30% |
| Earnings Yield | -27.83% | -27.62% | -25.27% | -37.74% | -57.64% | -29.56% |
| FCF Yield | -25.17% | -24.92% | -21.58% | -34.12% | -49.88% | -24.44% |
| Buyback Yield / Dilution | -21.24% | -12.88% | -81.58% | -38.41% | -42.69% | -125.89% |